Imara Announces Interim Analysis Data from Forte Phase 2b Clinical Trial of Tovinontrine (IMR-687) in Transfusion-Dependent Subjects with Beta-thalassemia
16th November 2021
Portfolio
This post references, or is about Imara. Find out more by clicking below
Print Article
Email Article
Save Article
